Cargando…
Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry
BACKGROUND: Halting progression of chronic kidney disease (CKD) to established end stage kidney disease is a major goal of global health research. The mechanism of CKD progression involves pro-inflammatory, pro-fibrotic, and vascular pathways, but pathophysiological differentiation is currently lack...
Autores principales: | Ramírez Medina, Carlos R., Ali, Ibrahim, Baricevic-Jones, Ivona, Odudu, Aghogho, Saleem, Moin A., Whetton, Anthony D., Kalra, Philip A., Geifman, Nophar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116780/ https://www.ncbi.nlm.nih.gov/pubmed/37076799 http://dx.doi.org/10.1186/s12014-023-09405-0 |
Ejemplares similares
-
OptiMissP: A dashboard to assess missingness in proteomic data-independent acquisition mass spectrometry
por: Arioli, Angelica, et al.
Publicado: (2021) -
The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discrimination
por: McGurk, Kathryn A, et al.
Publicado: (2020) -
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus
por: Su, Kevin Y. C., et al.
Publicado: (2023) -
Proteomics and Informatics for Understanding Phases
and Identifying Biomarkers in COVID-19 Disease
por: Whetton, Anthony D., et al.
Publicado: (2020) -
Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases
por: Salie, M. Taariq, et al.
Publicado: (2022)